Action:
To amend Chapter 180
Action 2365
General Information
Action Summary |
The major changes to these sections include the prohibition of anabolic or androgenic steroids, or both, and other like substances, except for boldenone, stanozolol, nandrolone, and testosterone individually but not in combination (stacking or layering) and a clarification of when adjunct bleeder medications can be given on race day (no less than three hours before post time). These rule changes are consistent with the Model Rules of Racing published by the Association of Racing Commissioners International. |
Chapters Affected |
Only affects this chapter.
|
Executive Branch Review |
This Action is exempt from Article 2 of the Administrative Process Act.
The normal executive branch review process is not required. As such, it can be submitted directly for publication and
is effective upon publication.
Exempt Citation:
2.2-4002 (B)(23)
|
RIS Project |
No project yet assigned to this action |
New Periodic Review |
This action will not be used to conduct a new periodic review.
|
Stages
Stages associated with this regulatory action.
Stage ID |
Stage Type |
Status |
4146
|
Final
|
Stage complete. This regulation became effective on 05/18/2007. |
Contact Information
Name / Title:
|
Kimberly Mackey
/
Regulatory Coordinator
|
Address:
|
5707 Huntsman Road
Suite 201-B
Richmond, VA 23250
|
Email Address:
|
Kimberly.Mackey@vrc.virginia.gov
|
Phone:
|
(804)966-7406
FAX: ()-
TDD: ()-
|
This person is the primary contact for this board.